U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 94

Tests names and labsConditionsGenes, analytes, and microbesMethods

Factor V Leiden

Center for Genetics at Saint Francis Saint Francis Hospital
United States
11
  • T Targeted variant analysis

Factor V Leiden

Genetics Laboratory Shodair Children's Hospital
United States
11
  • T Targeted variant analysis

Factor V Leiden Thrombophilia

Molecular Genetics Laboratory London Health Sciences Centre
Canada
11
  • T Targeted variant analysis

Invitae Surgical Risk Screen

Invitae
United States
248
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

F5 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
51
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoNeuro Panel

Centogene AG - the Rare Disease Company
Germany
18861858
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Epilepsy Panel

Centogene AG - the Rare Disease Company
Germany
734744
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CentoIEM Panel

Centogene AG - the Rare Disease Company
Germany
669688
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Blood Coagulation Panel

Centogene AG - the Rare Disease Company
Germany
110112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CentoICU Panel

Centogene AG - the Rare Disease Company
Germany
829848
  • C Sequence analysis of the entire coding region

Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel

PreventionGenetics, part of Exact Sciences
United States
346160
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Thrombophilia, susceptibility to, due to factor V Leiden, 188055, Autosomal dominant (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Thrombophilia, susceptibility to, due to factor V Leiden, 188055, Autosomal dominant (F5 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Thrombophilia due to activated protein C resistance, 188055, Autosomal dominant; THPH2 (F5 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Thrombophilia due to activated protein C resistance, 188055, Autosomal dominant; THPH2 (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Invitae Genetic Health Screen

Invitae
United States
409164
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Cardio Screen

Invitae
United States
20881
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Pharmacogenetics Panel

Mako Medical Laboratories
United States
66
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Factor V Leiden Gene mutation

Molecular Diagnostics Children's Hospital of Wisconsin
United States
21
  • T Targeted variant analysis

Factor V Leiden

IBC Instituto de Bioquimica Clinica SRL
Argentina
21
  • X Mutation scanning of select exons

Results: 1 to 20 of 94

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.